The fundamental conclusions of the primary analysis were confirmed in that there was no survival benefit overall for patients with @ to @ metastases ; however , there was a benefit for the subset of patients with GPA @ to @ ( median survival time -LSB- MST -RSB- for WBRT + SRS vs WBRT alone was @ versus @ months , P = @ ) regardless of the number of metastases .